Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide

NCT01062971 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: dorzolamide-timolol-brimonidine

Sponsor

Laboratorios Sophia S.A de C.V.